{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"3.560","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"326,000,000","primaryexch":"香港交易所","ric":"1349.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0383,"inline_upper_strike_price":"","sedol":"6540470","am":"12.84","iv":"","ew_strike":"","as":"3.480","geographic_focus":null,"incorpin":"中華人民共和國","etp_baseCur":null,"ew_amt_os":"","bd":"3.470","registrar":"香港中央證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"1,000","update_time":"2025-09-28 00:06:03.0","lo52":"1.770","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"王海波","underlying_ric":"688505.SS","hi52":"5.290","issuer_name":"上海復旦張江生物醫藥股份有限公司 - H股","h_share_flag":true,"ew_sub_per_from":"","div_yield":"0.93","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"3.460","mkt_cap":"1.13","f_aum_hkd":null,"ew_sub_per_to":"","ls":"3.470","nav_date":"","csic_classification":"醫藥衛生","floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"-0.070","aum":"","issued_shares_class_B":null,"vo":"3.66","secondary_listing_flag":false,"listing_date":"2002年8月13日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"上海復旦張江生物醫藥股份有限公司 - H股","nm_s":"復旦張江","sym":"1349","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"上海復旦張江生物醫藥股份有限公司是一家主要從事生物醫藥的研究開發、生產製造和市場營銷業務的中國公司。該公司的產品包括鹽酸氨酮戊酸外用散（商品名：艾拉）和注射用海姆泊芬（商品名：复美達），以及鹽酸多柔比星脂質體注射液（商品名：裡葆多）。其產品主要用於皮膚性病治療和抗腫瘤治療。該公司在國內市場開展業務。","op":"3.510","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"16/12/2013","hsic_sub_sector_classification":"生物技術","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"中國<br/>上海市浦東<br/>張江高科技園區<br/>蔡倫路308號","pc":"-1.98","days_to_expiry":null,"underlying_code":null,"pe":"85.68","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"3.540","isin":"CNE1000000W4","moneyness":""}},"qid":"1759074364257"}
